相关实验视频

Updated: Apr 23, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

38.2K

传染性疾病. 传染性疾病. 当埃博拉病毒的保护失败时

Jon Cohen

    Science (New York, N.Y.)
    |October 4, 2014
    PubMed
    概括

    No abstract available in PubMed .

    更多相关视频

    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
    08:13

    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

    Published on: January 20, 2019

    23.0K
    In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
    09:04

    In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

    Published on: May 11, 2020

    12.7K

    相关实验视频

    Last Updated: Apr 23, 2026

    Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
    10:11

    Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

    Published on: September 27, 2014

    38.2K
    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
    08:13

    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

    Published on: January 20, 2019

    23.0K
    In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
    09:04

    In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

    Published on: May 11, 2020

    12.7K

    相关概念视频

    Cross-reactivity00:42

    Cross-reactivity

    28.7K
    Overview
    28.7K
    Vaccinations01:51

    Vaccinations

    43.7K
    Overview
    43.7K
    Vaccine Production01:23

    Vaccine Production

    120
    Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
    120
    Vaccines01:21

    Vaccines

    64
    Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
    64
    JoVE
    关于 JoVE
    概览领导团队博客JoVE 帮助中心
    作者
    出版流程编辑委员会范围与政策同行评审常见问题投稿
    图书馆员
    用户评价订阅访问资源图书馆顾问委员会常见问题
    研究
    JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
    教育
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
    使用条款与条件
    隐私政策
    政策
    Jove
    Visualize
    联系我们